Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0ecbe06a-48e7-4209-bad0-726384071c4a
Date 7/24/2014
Company Name Augmenix
Mailing Address 204 2nd Avenue Lower Level Waltham, MA 02451 USA
Company Description Augmenix, Inc. is a privately held medical device company developing in-situ formed, space-filling hydrogels specifically for radiation oncology and cancer surgery indications. Augmenix, Inc.’s initial product will be the first synthetic tissue spacer designed and indicated to reduce radiation exposure of normal tissues adjacent to prostate cancers.
Proceeds Purposes These funds are anticipated to see Augmenix through to SpaceOAR System approval and US market launch, with commercialization activities expected to commence in earnest in 2015.